Japan News
-
Japan's Sumitomo to establish regenerative medicine and cell therapy joint venture
Japan | News | 0 Comment | 20 Dec, 2024
Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...Read more
-
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan
Japan | News | 0 Comment | 18 Dec, 2024
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...Read more
-
Japan's Shimadzu develops platform to support gene therapy manufacturing
Japan | News | 0 Comment | 17 Dec, 2024
Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...Read more
-
Eisai Subsidiary inks €117 M deal for schizophrenia treatment in Japan and other Asian territories
Japan | News | 0 Comment | 16 Dec, 2024
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...Read more
-
TMC Japan BioBridge to provide Japanese healthcare innovators path to enter US market
Japan | News | 0 Comment | 10 Dec, 2024
Texas Medical Center (TMC), in the US, in partnership with Japan-based organisations Mitsui Fudosan Co. and&nb...Read more
-
Israel's Teva Pharma to divest business venture in Japan
Japan | News | 0 Comment | 06 Dec, 2024
Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...Read more
-
SOHM, Inc. secures key patent in Japan for revolutionary gene editing technology
Japan | News | 0 Comment | 27 Nov, 2024
SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, ...Read more
-
Eisai and Biogen Japan collaborate to lead dementia genomics R&D with NCNP in Japan
Japan | News | 0 Comment | 26 Nov, 2024
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...Read more
-
IIT Roorkee and Kyoto University open joint-research lab in Japan with focus on healthy ageing
Japan | News | 0 Comment | 25 Nov, 2024
The Indian Institute of Technology (IIT) Roorkee and Kyoto University have announce the inauguration of a joint research...Read more
-
Japan | News | 0 Comment | 23 Nov, 2024
US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...Read more
-
Singleron Joins Forces with TOMY Digital Biology to Transform Single Cell Analysis in Japan
Japan | News | 0 Comment | 20 Nov, 2024
Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with ...Read more
-
Kaken Pharmaceutical and Numab Therapeutics collaborate on inflammatory bowel disease treatment
Japan | News | 0 Comment | 15 Nov, 2024
Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...Read more
-
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan
Japan | News | 0 Comment | 18 Nov, 2024
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...Read more
-
Japan’s GHIT Fund invests $4 M to advance diagnostics and treatments for NTDs and malaria
Japan | News | 0 Comment | 08 Nov, 2024
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 mi...Read more
-
Inocras and Summit Pharma International Corp collaborate to transform clinical genomics in Japan
Japan | News | 0 Comment | 06 Nov, 2024
US-based Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of understanding (Mo...Read more
-
Japan | News | 0 Comment | 05 Nov, 2024
Eisai Co. and Eisai’s corporate venture capital subsidiary, Eisai Innovation, Inc. have announced that Eisai Innov...Read more
-
Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market
Japan | News | 0 Comment | 04 Nov, 2024
Japan-headquartered Shimadzu Corporation has announced its investment in US-based Sepragen Corporation, a leading compan...Read more
-
Japan's I Peace announces new iPSC lines to reduce immune rejection risk for US population
Japan | News | 0 Comment | 01 Nov, 2024
Japan-based GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell th...Read more
